What Changed

Bavarian Nordic A/S published company announcement number 42/2026. The company is described as the preferred supplier of mpox and smallpox vaccines to governments. Its share buy-back program launched on September 1, 2026, and the most recent transaction under the program was announced on September 7, 2026.

A wide view of laboratory glassware and measuring instruments arranged on a workspace with soft side lighting, suggesting precision and methodical process.
Bavarian Nordic Details Buy-Back in Filing 42/2026

Highlights

  • Bavarian Nordic A/S published company announcement number 42/2026.
  • The company's share buy-back program launched on September 1, 2026.
  • Total treasury shares held stand at 3,842,026.
  • Nordea acts as transaction agent for Bavarian Nordic.

Program Details

Bavarian Nordic A/S trades under the ticker OMX: BAVA. Nordea acts as transaction agent for Bavarian Nordic. Total treasury shares held under the program stand at 3,842,026. The buy-back is carried out under Regulation (EU) No. 596/2014 and Commission Delegated Regulation (EU) 2016/1052, known as the Safe Harbour Regulation.